Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.

Grotzer MA, Janss AJ, Phillips PC, Trojanowski JQ

Open source

DOI
10.1055/s-2000-10044
Published
2000 Jul-Aug
Container
Klinische Padiatrie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/s-2000-10044,
  title = {Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.},
  author = {Grotzer MA and Janss AJ and Phillips PC and Trojanowski JQ},
  year = {2000},
  journal = {Klinische Padiatrie},
  doi = {10.1055/s-2000-10044},
  url = {https://doi.org/10.1055/s-2000-10044}
}

RIS

TY  - JOUR
TI  - Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
AU  - Grotzer MA
AU  - Janss AJ
AU  - Phillips PC
AU  - Trojanowski JQ
PY  - 2000
JO  - Klinische Padiatrie
DO  - 10.1055/s-2000-10044
UR  - https://doi.org/10.1055/s-2000-10044
ER  - 

APA

MA, G., AJ, J., PC, P., & JQ, T. (2000). Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.. Klinische Padiatrie. https://doi.org/10.1055/s-2000-10044

Source records